Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.

Abstract

Most patients born after 1974 survive to at least the age of 30. There has been a marked improvement in survival for patients of all ages since 2000, which may be due to the introduction of combination chelation therapy.